摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-Methoxyphenyl)-3-naphthalen-2-ylurea | 251917-79-0

中文名称
——
中文别名
——
英文名称
1-(2-Methoxyphenyl)-3-naphthalen-2-ylurea
英文别名
——
1-(2-Methoxyphenyl)-3-naphthalen-2-ylurea化学式
CAS
251917-79-0
化学式
C18H16N2O2
mdl
——
分子量
292.3
InChiKey
ISADADAHPHHLEM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    50.4
  • 氢给体数:
    2
  • 氢受体数:
    2

文献信息

  • Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
    申请人:Cenix Bioscience GmbH
    公开号:EP1832283A1
    公开(公告)日:2007-09-12
    The present invention relates to the use of inhibitors of scavenger receptor class proteins, in particular ScarB1 for the production of a medicament for treatment of and/or prophylaxis against infections, involving liver cells and/or hematopoietic cells, in particular malaria.
    本发明涉及使用清道夫受体类蛋白,特别是 ScarB1 的抑制剂来生产治疗和/或预防涉及肝细胞和/或造血细胞,特别是疟疾的感染的药物。
  • Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases
    申请人:Hannus Michael
    公开号:US20090324580A1
    公开(公告)日:2009-12-31
    The present invention relates to the use of inhibitors of scavenger receptor class proteins, in particular ScarB1 for the production of a medicament for treatment of and/or prophylaxis against infections, involving liver cells and/or hematopoietic cells, in particular malaria.
  • USE OF INHIBITORS OF SCAVENGER RECEPTOR CLASS PROTEINS FOR THE TREATMENT OF INFECTIOUS DISEASES
    申请人:HANNUS MICHAEL
    公开号:US20120276121A1
    公开(公告)日:2012-11-01
    The present invention relates to the use of inhibitors of scavenger receptor class proteins, in particular ScarB1 for the production of a medicament for treatment of and/or prophylaxis against infections, involving liver cells and/or hematopoietic cells, in particular malaria.
  • INACTIVATION OF MICROORGANISMS WITH MULTIDRUG RESISTANCE INHIBITORS AND PHENOTHIAZINIUMS
    申请人:Hamblin Michael R.
    公开号:US20130115133A1
    公开(公告)日:2013-05-09
    The present invention relates the use of phenothiaziniums and microbial MDR inhibitors to inactivate microorganisms. Methods of the present invention are useful in the treatment of living subjects and in the decontamination of inanimate objects and substances.
  • US8507546B2
    申请人:——
    公开号:US8507546B2
    公开(公告)日:2013-08-13
查看更多